FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...